British pharmaceutical giant GlaxoSmithKline on Monday announced a five-year investment programme for sub-Saharan Africa to fuel the company’s growth and to serve an area with “pressing health needs”. GSK will invest up to £130 million ($216 million…
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate